The cost-effectiveness of therapies to treat alcohol use disorders

References

• GBD. 2016 Risk factors collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1345–1422.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global status report on alcohol and health. Geneva, Switzerland: World Health Organization; 2014.
   Google Scholar
• Rehm J, Imtiaz S. Alcohol consumption as a risk factor for global burden of disease. A narrative review. Subst Abuse Treat Prev Policy. 2016;11:37.
   PubMed Web of Science ®Google Scholar
• Rehm J, Shield KD, Rehm MX, et al. Modelling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol. 2013;23:89–97.
   PubMed Web of Science ®Google Scholar
• Schwarzinger M, Thiébaut SP, Baillot S, et al. Alcohol use disorders and associated chronic disease - a national retrospective cohort study from France. BMC Public Health. 2018;18:43.
   Web of Science ®Google Scholar
• Westman J, Wahlbeck K, Laursen TM, et al. Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden. Acta Psychiat Scand. 2015;131:297–306.
   PubMed Web of Science ®Google Scholar
• Anderson P, Braddick F, Conrod P, et al. The new governance of addictive substances and behaviours. Oxford, U.K.: Oxford University Press; 2017.
   Google Scholar
• Rehm J, Shield KD, Rehm MX, et al. Alcohol consumption, alcohol dependence, and attributable burden of disease in Europe: potential gains from effective interventions for alcohol dependence. Toronto, Canada: Centre for Addiction and Mental Health; 2012.
   Google Scholar
• Caetano R, Cunradi C. Alcohol dependence: a public health perspective. Addiction. 2002;97:633–645.
   PubMed Web of Science ®Google Scholar
• Berglund M, Thelander S, Jonsson E. Treating alcohol and drug abuse. An evidenced based review. Weinheim, Germany: Wiley-VCH Verlag; 2003.
   Google Scholar
• Hester RK, Miller WR. Handbook of alcoholism treatment approaches. Effective alternatives. 3rd ed. Boston USA: Allyn & Bacon; 2003.
   Google Scholar
• Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311:1889–1900.
   PubMed Web of Science ®Google Scholar
• Kenna GA, Leggio L. Alcohol use disorder. In: MacKillop J, Kenna GA, Leggio L, et al., editors. integrating psychological and pharmacological treatments for addictive disorders. New York, NY: Routledge; 2018. p. 77–98.
   Google Scholar
• Cohen E, Feinn R, Arias A, et al. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007;86:214–221.
   PubMed Web of Science ®Google Scholar
• Kohn R, Saxena S, Levav I, et al. The treatment gap in mental health care. Bull World Health Org. 2004;82:858–866.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. New York, NY: Oxford University Press; 2005.
   Google Scholar
• Connor JP, Haber PS, Hall W. Alcohol use disorders. Lancet. 2015;387:988–998.
   PubMed Web of Science ®Google Scholar
• Schuckit MA. Alcohol-use disorders. Lancet. 2009;373:492–501.
   PubMed Web of Science ®Google Scholar
• Rehm J, Manthey J, Struzzo P, et al. Who receives treatment for alcohol use disorders in the European Union? A cross-sectional representative study in primary and specialized health care. Euro Psych. 2015;30:885–893.
   Google Scholar
• World Health Organization. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993.
   Google Scholar
• American Psychiatric Association. Substance use and addiction-related disorders. In: Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association,; 2013. p. 481–589.
   Google Scholar
• Rehm J, Allamani A, Elekes Z, et al. General practitioners recognizing alcohol dependence: a large cross-sectional study in six European countries. Ann Fam Med. 2015;13:28–32.
   PubMed Web of Science ®Google Scholar
• Rehm J, Room R. Cultural specificity in alcohol use disorders. Lancet. 2015 Sep 3. pii: S0140-6736(15)00123-3. doi: 10.1016/S0140-6736(15)00123-3. [Epub ahead of print].
   Google Scholar
• Rehm J, Room R. The cultural aspect: how to measure and interpret epidemiological data on alcohol use disorders across cultures. Nordisk Alkohol Nark. 2017;34:330–341.
   Google Scholar
• McHugh RK, Hearon BA, Otto MW. Cognitive-Behavioral Therapy for substance use disorders. Psychiatr Clin North Am. 2010;33:511–525.
   PubMed Web of Science ®Google Scholar
• Rösner S, Hackl-Herrwerth A, Leucht S, et al. Acamprosate for alcohol dependence. Cochrane Database Syst Rev. 2010;9:CD004332.
   PubMed Web of Science ®Google Scholar
• Rösner S, Hackl-Herrwerth A, Leucht S, et al. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;12:CD001867.
   PubMed Web of Science ®Google Scholar
• Leucht S, Helfer B, Gartlehner G, et al. How effective are common medications: a perspective based on meta-analyses of major drugs. BMC Med. 2015;13:253.
   PubMed Web of Science ®Google Scholar
• MacKillop J, Kenna GA, Leggio L, et al. Integrating psychological and pharmacological treatments for addictive disorders. New York, NY: Routledge; 2018.
   Google Scholar
• Sher KJ. The Oxford Handbook of Substance use and substance use disorders. New York, NY: Oxford University Press; 2016.
   Google Scholar
• Ghodse H, Herrman H, Maj M, et al. Substance Abuse Disorders. West Sussex, UK: Wiley-Blackwell; 2011.
   Google Scholar
• Becker P, Kayo M. Cost-effectiveness of interventions for the treatment of alcohol and other substance use disorders. In: Razzouk D, editor. Mental health economics. London, UK: Springer International Publishing; 2017. p. 323–338.
   Google Scholar
• Angus C, Latimer N, Preston L, et al. What are the implications for policy makers? A systematic review of the cost-effectiveness of screening and brief interventions for alcohol misuse in primary care. Front Psychiatry. 2014;5:114.
   PubMed Web of Science ®Google Scholar
• Jonas DE, Garbutt JC, Amick HR, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2012;157:645–654.
   PubMed Web of Science ®Google Scholar
• Solberg LI, Maciosek MV, Edwards NM. Primary care intervention to reduce alcohol misuse ranking its health impact and cost effectiveness. Am J Prev Med. 2008;34:143–152.
   PubMed Web of Science ®Google Scholar
• Taguchi Y, Yoshimoto H, Ikeda S. Considerations of screening and brief intervention among high-risk drinkers in Japan: from the perspectives of feasibility and cost-effectiveness. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2016;51:13–25.
   PubMedGoogle Scholar
• Barbosa C, Godfrey C, Parrott S. Methodological assessment of economic evaluations of alcohol treatment. What is missing? Alcohol Alcohol. 2010;45:53–63.
   PubMed Web of Science ®Google Scholar
• Suijkerbuijk AW, Van Gils PF, Greeven PG, et al. De kosteneffectiviteit van interventies gericht op verslaving aan alcohol en drugs. [Cost-effectiveness of addiction care]. Tijdschrift Voor Psychiatrie. 2015;57:498–507.
   PubMedGoogle Scholar
• Palmer A, Neeser K, Weiss C, et al. The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. Alcohol Alcohol. 2000;35:478–492.
   PubMed Web of Science ®Google Scholar
• Walters D, Connor JP, Feeney GF, et al. The cost effectiveness of naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence. J Addict Disord. 2009;28:137–144.
   PubMed Web of Science ®Google Scholar
• Heather N, Copello A, Godfrey C, et al. Cost-effectiveness of treatment for alcohol problems: findings of the randomised UK Alcohol Treatment Trial (UKATT). Bmj. 2005;331:544.
   PubMedGoogle Scholar
• Sassi F, Cecchini M, Deveaux M, et al. Health and economic impacts of key alcohol policy options. In: Sassi F, editor. Tackling harmful alcohol use. Paris, France: OECD; 2015. p. 141–180.
   Google Scholar
• World Health Organization. Cost effectiveness and strategic planning. 2017 [cited 2017 Aug 17]. Available from: http://www.who.int/choice/en/.
   Google Scholar
• Chisholm D, Doran C, Shibuya K, et al. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev. 2006;25:553–565.
   PubMed Web of Science ®Google Scholar
• Chisholm D, Rehm J, van Ommeren M, et al. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol. 2004;65:782–793.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Draft - Updated Appendix 3 of the WHO Global NCD Action Plan 2013-2020. [ cited 2017 Aug 16]. Available from: http://who.int/ncds/governance/discussion-paper-updating-appendix3-25july2016-EN.pdf.
   Google Scholar
• World Health Organization. Global action plan for the prevention and control of NCDs 2013-2020. Geneva, Switzerland: World Health Organization; 2013.
   Google Scholar
• Holder H, Longabaugh R, Miller WR, et al. The cost effectiveness of treatment for alcoholism: a first approximation. J Stud Alcohol. 1991;52:517–540.
   PubMed Web of Science ®Google Scholar
• Finney J, Monahan S. The cost-effectiveness of treatment for alcoholism: a second approximation. J Stud Alcohol. 1996;57:229–243.
   PubMed Web of Science ®Google Scholar
• Howard MO. Assessing the comparative cost-effectiveness of alcoholism treatments: a comment on Holder, Longabaugh, Miller and Rubonis. J Stud Alcohol. 1993;54:667–675.
   PubMed Web of Science ®Google Scholar
• Slattery J, Chick J, Cochrane M, et al. Prevention of relapse in alcohol dependence. Glasgow, Scotland: Scotland HTBf; 2003.
   Google Scholar
• Holder HD. The cost offsets of alcoholism treatment. Recent Dev Alcohol. 1998;14:361–374.
   PubMedGoogle Scholar
• Holder HD. Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse. J Ment Health Policy Econ. 1998;1:23–29.
   PubMedGoogle Scholar
• Holder HD, Blose JO. The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study. J Stud Alcohol. 1992;53:293–302.
   PubMed Web of Science ®Google Scholar
• Blose JO, Holder HD. The utilization of medical care by treated alcoholics: longitudinal patterns by age, gender, and type of care. J Subst Abuse. 1991;3:13–27.
   PubMedGoogle Scholar
• Holder HD, Blose JO. Changes in health care costs and utilization associated with mental health treatment. Hosp Community Psychiatry. 1987;38:1070–1075.
   PubMedGoogle Scholar
• Holder HD, Hallan JB. Impact of alcoholism treatment on total health care costs: a six-year study. Adv Alcohol Subst Abuse. 1986;6:1–15.
   PubMedGoogle Scholar
• Holder HD, Cisler RA, Longabaugh R, et al. Alcoholism treatment and medical care costs from Project MATCH. Addiction. 2000;95:999–1013.
   PubMed Web of Science ®Google Scholar
• UKATT Research Team. United Kingdom Alcohol Treatment Trial (UKATT): hypotheses, design and methods. Alcohol Alcohol. 2001;36:11–21.
   PubMed Web of Science ®Google Scholar
• Zarkin GA, Bray JW, Aldridge A, et al. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients. Arch Gen Psychiatry. 2008;65:1214–1221.
   PubMedGoogle Scholar
• Dunlap LJ, Zarkin GA, Bray JW, et al. Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective. Medical Care. 2010;48:306–313.
   PubMed Web of Science ®Google Scholar
• Anton R, O’Malley S, Ciraulo D, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: a randomized controlled trial. JAMA. 2006;17:2003–2017.
   Google Scholar
• Mann K, Torup L, Sørensen P, et al. Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy. Eur Neuropsychopharmacol. 2016;26:1941–1949.
   PubMed Web of Science ®Google Scholar
• Laramée P, Brodtkorb TH, Rahhali N, et al. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol dependent patients with high/very high drinking risk levels: a Markov model. BMJ Open. 2014;4:e005376.
   PubMed Web of Science ®Google Scholar
• Laramée P, Millier A, Brodtkorb TH, et al. A comparison of Markov and discrete-time microsimulation approaches: simulating the avoidance of alcohol-attributable harmful events from reduction of alcohol consumption through treatment of alcohol dependence. Clinical Drug Investigation. 2016;36:945–956.
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Co-operation and Development. Tackling harmful alcohol use: economics and public health policy. Paris: Organisation for Economic Co-operation and Development; 2015.
   Google Scholar
• Rehm J, Dawson D, Frick U, et al. Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res. 2014;38:1068–1077.
   PubMed Web of Science ®Google Scholar
• Rehm J, Allamani A, Elekes Z, et al. Alcohol dependence and treatment utilization in Europe - a representative cross-sectional study in primary care. BMC Fam Prac. 2015;16:90.
   PubMed Web of Science ®Google Scholar
• Kraus L, Piontek D, Pfeiffer-Gerschel T, et al. Inanspruchnahme gesundheitlicher versorgung durch alkoholabhängige [health care utilization of people with alcohol dependence]. Suchtherapie. 2015;16:18–26.
   Google Scholar
• Lui S, Terplan M, Smith EJ. Psychosocial interventions for women enrolled in alcohol treatment during pregnancy. Cochrane Database Syst Rev. 2008;16:CD06753.
   Google Scholar
• Morley KC, Teesson M, Reid SC, et al. Natrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomised, double-blined, placebo-controlled trial. Addiction. 2006;101:1451–1462.
   PubMed Web of Science ®Google Scholar
• Baltieri DA, Guerra De Andrade A. Acamprosate in alcohol dependence: a randomized controlled efficacy study in a standard clinical setting. J Stud Alcohol. 2004;65:136–139.
   PubMed Web of Science ®Google Scholar
• Anderson P, Møller L, Galea G. Alcohol in the European Union: consumption, harm and policy approaches. Copenhagen: World Health Organization; 2012.
   Google Scholar
• Mason BJ, Goodman AM, Chabac S, et al. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res. 2006;40:383–393.
   PubMed Web of Science ®Google Scholar
• Roozen HG, de Waart R, van der Windt DA, et al. A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. Eur Neuropsychopharmacol. 2006;16:311–323.
   PubMed Web of Science ®Google Scholar
• Purshouse CR, Meier PS, Brennan A, et al. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model. Lancet. 2010;375:1355–1364.
   PubMed Web of Science ®Google Scholar
• Babor T, Caetano R, Casswell S, et al. Alcohol: no ordinary commodity. Research and public policy. 2nd. Oxford and London: Oxford University Press; 2010.
   Google Scholar
• Anderson P, Chisholm D, Fuhr D. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009;373:2234–2246.
   PubMed Web of Science ®Google Scholar
• Babor TF, Higgins-Biddle JC. Brief Intervention - For hazardous and harmful drinking. In: A manual for use in primary care. Geneva, Switzerland: World health Organization; 2001.
   Google Scholar
• Babor T, Higgins-Biddle J, Saunders J, et al. AUDIT - The alcohol use disorders identification test: guidelines for use in primary care. 2 ed. Geneva: World Health Organization; 2001.
   Google Scholar
• Kaner EF, Beyer F, Dickinson HO, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;18:CD004148.
   Google Scholar
• Álvarez-Bueno C, Rodríguez-Martín B, García-Ortiz L, et al. Effectiveness of brief interventions in primary health care settings to decrease alcohol consumption by adult non-dependent drinkers: a systematic review of systematic reviews. Prev Med. 2015;76(Suppl):S33–S8.
   PubMedGoogle Scholar
• McQueen J, Howe TE, Allan L, et al. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev. 2011;8:CD005191.
   Google Scholar
• Barbosa C, Cowell A, Bray J, et al. The cost-effectiveness of alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) in emergency and outpatient medical settings. J Subst Abuse Treat. 2015;53:1–8.
   PubMed Web of Science ®Google Scholar
• Barbosa C, Cowell A, Dowd W, et al. The cost-effectiveness of brief intervention versus brief treatment of Screening, Brief Intervention and Referral to Treatment (SBIRT) in the United States. Addiction. 2017;112 Suppl 2:73–81.
   PubMed Web of Science ®Google Scholar
• Angus C, Thomas C, Anderson P, et al. Estimating the cost-effectiveness of brief interventions for heavy drinking in primary health care across Europe. Eur J Public Health. 2017;27:345–351.
   PubMed Web of Science ®Google Scholar
• Anderson P, Bendtsen P, Spak F, et al. Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the Optimizing Delivery of Health Care Intervention (ODHIN) five-country cluster randomized factorial trial. Addiction. 2016;111:1935–1945.
   PubMed Web of Science ®Google Scholar
• Colom J, Scafato E, Segura L, et al. Brief interventions implementation on alcohol from the European health systems perspective. Front Psychiatry. 2014;5:161.
   PubMed Web of Science ®Google Scholar
• Nilsen P. Brief alcohol intervention-where to from here? Challenges remain for research and practice. Addiction. 2010;105:954–959.
   PubMed Web of Science ®Google Scholar
• Drummond C, Wolstenholme A, DeLuca P, et al. Alcohol interventions and treatments in Europe. Anderson P, Braddick F, Reynolds J, et al., editors. Alcohol Policy in Europe: evidence from AMPHORA. 2nd ed. Barcelona:AMPHORA; 2013. p.65–80.
   Google Scholar
• Johnson M, Jackson R, Guillaume L, et al. Barriers and facilitators to implementing screening and brief intervention for alcohol misuse: a systematic review of qualitative evidence. J Public Health. 2011;33:412–421.
   Web of Science ®Google Scholar
• Probst C, Manthey J, Martinez A, et al. Alcohol use disorder severity and reported reasons not to seek treatment: a cross-sectional in European primary care practices. Subst Abuse Treat Prev Policy. 2015;10:32.
   PubMed Web of Science ®Google Scholar
• Wallhed Finn S, Bakshi AS, Andreasson S. Alcohol consumption, dependence, and treatment barriers: perceptions among nontreatment seekers with alcohol dependence. Subst Use Misuse. 2014;49:762–769.
   PubMed Web of Science ®Google Scholar
• Rehm J, Anderson P, Arbesu Prieto JA, et al. Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Med. 2017;15:173.
   PubMed Web of Science ®Google Scholar
• McCambridge J, Rollnick S. Should brief interventions in primary care address alcohol problems more strongly? Addiction. 2014;109:1054–1058.
   PubMed Web of Science ®Google Scholar
• McCambridge J, Saitz R. Rethinking brief interventions for alcohol in general practice. Bmj. 2017;356:j116.
   PubMedGoogle Scholar
• Rehm J, Anderson P, Manthey J, et al. Alcohol use disorders in primary health care – what do we know and where do we go? Alcohol Alcohol. 2015;51:422–427.
   PubMed Web of Science ®Google Scholar
• Schomerus G, Lucht M, Holzinger A, et al. The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol. 2011;46:105–112.
   PubMed Web of Science ®Google Scholar
• Rehm J, Mathers C, Popova S, et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet. 2009;373:2223–2233.
   PubMed Web of Science ®Google Scholar
• Shield KD, Rehm MX, Rehm J. Social costs of addiction in Europe. In: Anderson P, Rehm J, Room R, editors. The impact of addictive substances and behaviours on individual and societal well-being. Oxford, UK: Oxford University Press; 2015. p. 181–188.
   Google Scholar